Sudarshan Pharma Industries Chart
Sudarshan Pharma Industries Share Key Metrics
Volume
1.04 L
Market Cap
716.92 CR
LTQ@LTP
20000@30.57
ATP
30.34
Var Margin
100 %
Circuit Range
28.31-31.27
Delivery %
100 %
Value
31.55 L
ASM/GSM
No
Market Lot
4000
Summary
Sudarshan Pharma Industries Fundamentals
View MoreP/E Ratio
30.77
P/B Ratio
4.62
Div. Yield
0
Sector P/E
66.86
Sector P/B
3.47
Sec. Div. Yield
0.56
Sudarshan Pharma Industries Resistance and Support
Pivot 29.18
Resistance
First Resistance
30.61
Second Resistance
31.43
Third Resistance
32.86
Support
First Support
28.36
Second Support
26.93
Third Support
26.11
Sudarshan Pharma Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-15 | Others |
| 2026-04-30 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-10-18 | Half Yearly Results |
| 2025-08-14 | Quarterly Results |
| 2025-06-19 | Others |
| 2025-04-24 | Audited Results |
| 2025-01-10 | To consider issue of Warrants |
Sudarshan Pharma Industries News
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Management
Sudarshan Pharma Industries appointed Mr. Sanat Bhat as Independent Director, Dr. Vinay Pandey as Non-Executive Director, and Mr. Sharad Govindrao Kathawate as Chief Financial Officer, effective May 1, 2026, strengthening its board and management team with diverse expertise.
Apr 30 2026 23:04:00
About Sudarshan Pharma Industries
NSE : 0
BSE : 543828
ISIN : INE00TV01023
The Company was originally incorporated under the Companies Act 1956 vide certificate of incorporation dated July 23 2008 issued by the Registrar of Companies Mumbai. Later in the year 2016 the name of the company was changed from Sudarshan Specialty Chemsolve Private Limited to Sudarshan Pharma Industries Private Limited under the Companies Act 2013 pursuant to a special resolution passed by the shareholders at the EGM held on November 25 2016 and vide certificate of incorporation dated December 17 2016 issued by the Registrar of Companies Mumbai. Thereafter the Company was converted in to a public company pursuant to a special resolution passed by the shareholders at the EGM held on December 12 2016 and consequently name was changed to Sudarshan Pharma Industries Limited (SPIL) vide fresh certificate of incorporation dated January 15 2017 issued by Registrar of Companies Mumbai. The CIN of the Company is U51496MH2008PLC184997.
Sudarshan Pharma Industries Management
| Name | Position |
|---|---|
| Nirav Shah | Company Secretary & Compliance Officer |
| Hemal Vasantrai Mehta | Chairman & Managing Director |
Sudarshan Pharma Industries Similar Stocks
Sudarshan Pharma Industries FAQs
